Company Overview - Weisi Medical's closing price on August 4 was 46.31 yuan, with an increase of 1.78%, resulting in a rolling price-to-earnings (PE) ratio of 39.10 times and a total market capitalization of 4.435 billion yuan [1] - The company operates in the medical device sector, focusing on the research, production, and sales of medical devices, including magnetic stimulation, electrical stimulation, electrophysiology, consumables and accessories, and laser radiofrequency products [1] Financial Performance - For the first quarter of 2025, Weisi Medical reported revenue of 95.9127 million yuan, representing a year-on-year increase of 9.40% [1] - The net profit for the same period was 33.2201 million yuan, showing a significant year-on-year growth of 52.71% [1] - The company's gross profit margin stood at 66.65% [1] Industry Comparison - The average PE ratio for the medical device industry is 54.32 times, with a median of 38.11 times, positioning Weisi Medical at the 79th rank within the industry [1] - The company has one institutional holder, which is a fund, holding a total of 90,000 shares valued at 0.04 million yuan [1] - The industry average PE (TTM) is 54.32, while the median is 38.11, indicating that Weisi Medical's PE ratio is below the industry average but above the median [2]
伟思医疗收盘上涨1.78%,滚动市盈率39.10倍,总市值44.35亿元